重点产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 711401 | Eganelisib ( IPI-549 ) | 1693758-51-8 | ≧98.0% | _1693758-51-8.png) |
| Eganelisib (IPI-549) 是一种首创、口服、高选择性 PI3Kγ 抑制剂，单独 | ||||
| 24067 | PBT434 氢溴酸盐 | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
| 233141 | NXP-800 ( CCT361814 ) | 1693734-80-3 | ≧98.0% |  |
| NXP800 是一种口服小分子热休克因子 1 (HSF1) 通路抑制剂。 NXP800 可 | ||||
| 20313 | Cenerimod ( ACT-334441 ) | 1262414-04-9 | ≧98.0% | _1262414-04-9.png) |
| Cenerimod 是一种有效的、具有口服活性免疫调节剂，EC50 值为 2.7 nM | ||||
| 822223 | Venglustat ( ibiglustat ) | 1401090-53-6 | ≧98.0% | _1401090-53-6.png) |
| Ibiglustat (Venglustat) 是一种具有口服活性的，可透过血脑屏障的葡萄 | ||||
| 822224 | 布瑞拉沙秦（Brilaroxazine） | 1239729-06-6 | ≧98.0% |  |
| RP-5063（Brilaroxazine） 是一种多模式的血清素和多巴胺受体调节剂， | ||||
| 822225 | Cadisegliatin (TTP-399) | 859525-02-3 | ≧98.0% |  |
| Cadisegliatin(TTP-399) 是一种潜在的肝脏选择性葡萄糖激酶 (GK) 激活剂 | ||||
| 51910 | TRV130 ( Oliceridine ) | 1401031-39-7 | ≧98.0% | _1401031-39-7.png) |
| TRV 130 Hcl(Oliceridine)是一种新颖的MOR 激动剂，能够优先激活 G-protei | ||||
| 191123 | Tafenoquine succinate ( 他非诺喹琥珀酸盐 ) | 106635-81-8 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 231106 | PDS-0330 | 2904682-19-3 | ≧98.0% |  |
| PDS-0330 是一种特异性、有效的Claudin-1抑制剂。PDS-0330 干扰 claudin-1 | ||||
| 16122939 | Emeramide ( BDTH2 ) | 351994-94-0 | ≧98.0% | _351994-94-0.png) |
| Emeramide, also known as BDTH2, is a mercury and heavy metal chelator. BDTH2 molecule | ||||
| 62502 | TG02 ( SB1317 ) | 937270-47-8 | ≧98.0% | _937270-47-8.png) |
| SB1317 (TG02) is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. SB1317 was so | ||||